2022-11-11 | Sale | 23andMe Holding Co. ME | director | 18,421 0.0039% | $3.24 | $59,684 | -40.24% | |
2021-08-05 | Sale | Alector, Inc. ALEC | director | 56,260 0.0673% | $27.68 | $1.56M | -43.83% | |
2021-08-04 | Sale | BridgeBio Pharma, Inc. BBIO | See Remarks | 13,777 0.0095% | $53.23 | $733,317 | -79.25% | |
2021-07-02 | Sale | Alector, Inc. ALEC | director | 9,981 0.0109% | $31.14 | $310,808 | -43.68% | |
2021-05-24 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 100 0.0003% | $25.00 | $2,500 | -32.7% | |
2021-05-21 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 1,231 0.0034% | $25.19 | $31,008 | -38.88% | |
2021-05-20 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 659 0.0018% | $25.08 | $16,528 | -39.05% | |
2021-05-18 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 2,800 0.0078% | $25.34 | $70,958 | -37.53% | |
2021-05-17 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 1,000 0.0027% | $25.06 | $25,060 | -37.92% | |
2021-05-14 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 9,230 0.0252% | $25.38 | $234,233 | -38.42% | |
2021-05-13 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 200 0.0006% | $25.00 | $5,000 | -35.56% | |
2021-05-12 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 206 0.0006% | $25.00 | $5,151 | -35.1% | |
2021-05-11 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 600 0.0017% | $25.16 | $15,096 | -36.4% | |
2021-04-30 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 200 0.0006% | $25.19 | $5,038 | -33.26% | |
2021-04-28 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 400 0.0011% | $25.11 | $10,044 | -34.48% | |
2021-04-01 | Sale | ORIC Pharmaceuticals, Inc. ORIC | director | 400 0.0012% | $25.00 | $10,000 | -25.97% | |
2020-12-21 | Sale | BridgeBio Pharma, Inc. BBIO | See Remarks | 60,401 0.0509% | $65.32 | $3.95M | -15.6% | |
2020-12-18 | Sale | BridgeBio Pharma, Inc. BBIO | See Remarks | 30,000 0.0255% | $65.07 | $1.95M | -14.12% | |
2020-12-15 | Sale | BridgeBio Pharma, Inc. BBIO | See Remarks | 31,443 0.0264% | $60.38 | $1.9M | -8.41% | |
2020-09-16 | Sale | BridgeBio Pharma, Inc. BBIO | See Remarks | 50,000 0.0424% | $37.50 | $1.88M | +50.63% |